Real world data that harnesses deidentified health records is a multi-billion-dollar industry. But what is the value of a ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 4, BMO Capital lifted the price target on the company’s ...

David Ellison’s Skydance Media has closed its $8 billion merger with Paramount Global to create new company Paramount Skydance Corp.

DOJ settlement would allow $3.3B UnitedHealth home health acquisition to move forward Agreement requires the Optum division of Eden Prairie-based UnitedHealth to divest at least 164 home health ...

Scott Everett Pulls Back the Curtain on S2 Capital’s Acquisition of Fort Capital The acquisition marks S2's first major push beyond multifamily since its founding in 2012.

The FTC moved to block Edwards Lifesciences’ buyout of JenaValve and its heart implant for aortic regurgitation, slated for FDA approval this year.

Energy Vault has formalized its investment position in the Stoney Creek BESS following receipt of Foreign Investment Review Board (FIRB) approval, enabling full acquisition and control of the ...

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier InvestorsAcquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive ...

Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically accompanies a big-money acquisition in the biopharma industry.

In Westchester County, Regeneron, a top bio-tech company, has workers focused on mRNA research projects, including one aimed at "unlocking the next generation of cancer fighting treatments ...

Ripple has acquired Rail, a stablecoin payments platform, as part of its push to offer an all-in-one stablecoin infrastructure.